High Court Preemption Ruling Would Hit Branded Cos. Hard

Law360, New York (May 23, 2011, 1:36 PM ET) -- If the U.S. Supreme Court finds that generic-drug makers are not liable for state failure-to-warn claims in a case alleging that federal regulations shield generics makers from such allegations, lawsuits against the drugs' original manufacturers will increase as plaintiffs with diminished options search for a party to blame for their injuries, attorneys say.

The Supreme Court held oral arguments on March 30 in a trio of consolidated appeals in which the high court will determine whether its 2009 landmark decision in Wyeth v. Levine, which held...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required